Clinical Report: Understanding Neovascular Glaucoma: Mechanisms, Diagnostic Approaches, and Current Treatment Strategies
Overview
Neovascular glaucoma (NVG) is a secondary glaucoma characterized by neovascularization of the iris and anterior chamber angle, primarily resulting from ischemic retinal diseases. This review discusses the pathophysiology, diagnostic methods, and treatment strategies for NVG.
Background
NVG poses significant challenges in management due to its association with high rates of vision loss and surgical failure. It commonly arises from ischemic retinal disorders. Advances in imaging and anti-VEGF therapies have improved detection and management.
Data Highlights
No numerical data available in the source material.
Key Findings
NVG is driven by retinal ischemia, leading to elevated intraocular VEGF and neovascularization.
Clinical staging of NVG ranges from early iris neovascularization to advanced angle closure with refractory IOP elevation.
Diagnosis involves slit-lamp examination, gonioscopy, and multimodal imaging techniques.
Intravitreal anti-VEGF injections can temporarily regress neovascularization but must be combined with treatments targeting retinal ischemia for long-term success.
Integrated care is essential for managing NVG.
Clinical Implications
Effective management of NVG requires a comprehensive approach that addresses both the neovascularization and the underlying ischemic conditions.
Conclusion
NVG remains a challenging condition with significant implications for patient vision and quality of life.
